» Articles » PMID: 2648131

C-myc RNA Degradation in Growing and Differentiating Cells: Possible Alternate Pathways

Overview
Journal Mol Cell Biol
Specialty Cell Biology
Date 1989 Jan 1
PMID 2648131
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

Transcripts of the proto-oncogene c-myc are composed of a rapidly degraded polyadenylated RNA species and an apparently much more stable, nonadenylated RNA species. In this report, the extended kinetics of c-myc RNA turnover have been examined in rapidly growing cells and in cells induced to differentiate. When transcription was blocked with actinomycin D in rapidly growing cells, poly(A)+ c-myc was rapidly degraded (t1/2 = 12 min). c-myc RNA lacking poly(A) initially remained at or near control levels; however, after 80 to 90 min it was degraded with kinetics similar to those of poly(A)+ c-myc RNA. These bizarre kinetics are due to the deadenylation of poly(A)+ c-myc RNA to form poly(A)- c-myc, thereby initially maintaining the poly(A)- c-myc RNA pool when transcription is blocked. In contrast to growing cells, cells induced to differentiate degraded both poly(A)+ and poly(A)- c-myc RNA rapidly. The rapid disappearance of both RNA species in differentiating cells suggests that a large proportion of the poly(A)+ c-myc RNA was directly degraded without first being converted to poly(A)- c-myc RNA. Others have shown that transcriptional elongation of the c-myc gene is rapidly blocked in differentiating cells. We therefore hypothesize that in differentiating cells a direct, rapid degradation of poly(A)+ c-myc RNA may act as a backup or fail-safe system to ensure that c-myc protein is not synthesized. This tandem system of c-myc turnoff may also make cells more refractory to mutations which activate constitutive c-myc expression.

Citing Articles

Roles of mRNA poly(A) tails in regulation of eukaryotic gene expression.

Passmore L, Coller J Nat Rev Mol Cell Biol. 2021; 23(2):93-106.

PMID: 34594027 PMC: 7614307. DOI: 10.1038/s41580-021-00417-y.


Regulation of low-density lipoprotein receptor expression in triple negative breast cancer by EGFR-MAPK signaling.

Scully T, Kase N, Gallagher E, LeRoith D Sci Rep. 2021; 11(1):17927.

PMID: 34504181 PMC: 8429745. DOI: 10.1038/s41598-021-97327-y.


Quantitative studies of Epstein-Barr virus-encoded microRNAs provide novel insights into their regulation.

Amoroso R, Fitzsimmons L, Thomas W, Kelly G, Rowe M, Bell A J Virol. 2010; 85(2):996-1010.

PMID: 21068248 PMC: 3020024. DOI: 10.1128/JVI.01528-10.


Identification of Apurinic/apyrimidinic endonuclease 1 (APE1) as the endoribonuclease that cleaves c-myc mRNA.

Barnes T, Kim W, Mantha A, Kim S, Izumi T, Mitra S Nucleic Acids Res. 2009; 37(12):3946-58.

PMID: 19401441 PMC: 2709568. DOI: 10.1093/nar/gkp275.


Control of c-myc mRNA stability by IGF2BP1-associated cytoplasmic RNPs.

Weidensdorfer D, Stohr N, Baude A, Lederer M, Kohn M, Schierhorn A RNA. 2008; 15(1):104-15.

PMID: 19029303 PMC: 2612774. DOI: 10.1261/rna.1175909.


References
1.
Prochownik E, Kukowska J . Deregulated expression of c-myc by murine erythroleukaemia cells prevents differentiation. Nature. 1986; 322(6082):848-50. DOI: 10.1038/322848a0. View

2.
Dmitrovsky E, Kuehl W, Hollis G, Kirsch I, Bender T, Segal S . Expression of a transfected human c-myc oncogene inhibits differentiation of a mouse erythroleukaemia cell line. Nature. 1986; 322(6081):748-50. DOI: 10.1038/322748a0. View

3.
Studzinski G, Brelvi Z, Feldman S, Watt R . Participation of c-myc protein in DNA synthesis of human cells. Science. 1986; 234(4775):467-70. DOI: 10.1126/science.3532322. View

4.
Eick D, Bornkamm G . Transcriptional arrest within the first exon is a fast control mechanism in c-myc gene expression. Nucleic Acids Res. 1986; 14(21):8331-46. PMC: 311862. DOI: 10.1093/nar/14.21.8331. View

5.
NEPVEU A, Marcu K . Intragenic pausing and anti-sense transcription within the murine c-myc locus. EMBO J. 1986; 5(11):2859-65. PMC: 1167235. DOI: 10.1002/j.1460-2075.1986.tb04580.x. View